Bio-Rad Laboratories (BIO) Cash & Equivalents Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | -11.19% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 47.04% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 14.53% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 11.35% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 3.13% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 63.22% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 39.99% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 14.33% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 26.35% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 100.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.99% |
| Mar 31, 2026 | -2.72% |
| Dec 31, 2025 | 8.54% |
| Sep 30, 2025 | -3.56% |
| Jun 30, 2025 | -9.24% |
| Mar 31, 2025 | 20.33% |
| Dec 31, 2024 | 20.88% |
| Sep 30, 2024 | -10.36% |
| Jun 30, 2024 | 4.33% |
| Mar 31, 2024 | -6.64% |
| Dec 31, 2023 | -7.00% |
| Sep 30, 2023 | -11.60% |
| Jun 30, 2023 | -34.63% |
| Mar 31, 2023 | -42.15% |
| Dec 31, 2022 | -7.77% |
| Sep 30, 2022 | -39.77% |
| Jun 30, 2022 | -18.59% |
| Mar 31, 2022 | 19.13% |
| Dec 31, 2021 | -28.91% |
| Sep 30, 2021 | 2.33% |